Market Closed -
Nasdaq
01:30:00 09/05/2024 am IST
5-day change
1st Jan Change
21.03
USD
-25.29%
-19.52%
-52.52%
Semler Scientific, Inc.(NasdaqCM:SMLR) added to Russell Small Cap Completeness Index
June 23, 2023 at 09:30 am IST
Semler Scientific, Inc.(NasdaqCM:SMLR) added to Russell Small Cap Completeness Index
Transcript : Semler Scientific, Inc., Q1 2024 Earnings Call, May 07, 2024
08/05
Earnings Flash (SMLR) SEMLER SCIENTIFIC Posts Q1 Revenue $15.9M, vs. Street Est of $21.4M
08/05
MT
Semler Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
08/05
CI
Transcript : Semler Scientific, Inc., Q4 2023 Earnings Call, Mar 05, 2024
06/03
Earnings Flash (SMLR) SEMLER SCIENTIFIC Posts Q4 Revenue $15.1M, vs. Street Est of $14.5M
06/03
MT
Semler Scientific, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
06/03
CI
Tranche Update on Semler Scientific, Inc.'s Equity Buyback Plan announced on March 14, 2022.
14/11
CI
Transcript : Semler Scientific, Inc., Q3 2023 Earnings Call, Nov 09, 2023
10/11
Semler Scientific, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
10/11
CI
Earnings Flash (SMLR) SEMLER SCIENTIFIC Reports Q3 Revenue $16.3M, vs. Street Est of $15.2M
10/11
MT
Semler Scientific, Inc. Announces Steps Down of Abbie" Leibowitz as Class II Director
24/23/24
CI
Semler Scientific Insider Bought Shares Worth $2,147,273, According to a Recent SEC Filing
14/23/14
MT
Uptick in Producer-Price Inflation Weighs on Sentiment, Stifling US Equity Futures Pre-Bell
11/23/11
MT
Top Premarket Gainers
11/23/11
MT
Transcript : Semler Scientific, Inc., Q2 2023 Earnings Call, Aug 10, 2023
11/23/11
Earnings Flash (SMLR) SEMLER SCIENTIFIC Reports Q2 Revenue $18.6M, vs. Street Est of $16M
11/23/11
MT
Semler Scientific, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
11/23/11
CI
Tranche Update on Semler Scientific, Inc.'s Equity Buyback Plan announced on March 14, 2022.
10/23/10
CI
Semler Scientific Names CFO, Plans 30% Workforce Reduction
11/23/11
MT
Semler Scientific, Inc. to Reduce Headcount by Approximately 30%
11/23/11
CI
Semler Scientific, Inc. Announces Executive Changes
11/23/11
CI
Semler Scientific, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2023
11/23/11
CI
Semler Scientific, Inc. Appoints Cormier as CFO
11/23/11
CI
Semler Scientific to Join Russell 2000, Russell 3000 Indexes Monday
24/23/24
MT
Semler Scientific, Inc.(NasdaqCM:SMLR) added to Russell 3000 Index
23/23/23
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patientâs vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
More about the company
Last Close Price
28.15
USD
Average target price
65
USD
Spread / Average Target
+130.91%
Consensus
1st Jan change
Capi.
-52.52% 198M +73.50% 12.41B -19.26% 8.14B +2.40% 7.2B +3.66% 5.93B +11.89% 5.43B +37.45% 4.89B -19.82% 4.09B -35.58% 2.49B +0.74% 2.04B
Medical Equipment
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
SEMLER SCIENTIFIC, INC. 